Baby Safety / Compounds / Methamphetamine

Is Methamphetamine safe for babies and kids?

Extreme risk for kids

Infants are more vulnerable to Methamphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is methamphetamine?

The IUPAC name is (2S)-N-methyl-1-phenylpropan-2-amine.

Also known as: (2S)-N-methyl-1-phenylpropan-2-amine, Metamfetamine, d-Deoxyephedrine, Metamphetamine.

IUPAC name
(2S)-N-methyl-1-phenylpropan-2-amine
CAS number
537-46-2
Molecular formula
C10H15N
Molecular weight
149.23 g/mol
SMILES
CC(CC1=CC=CC=C1)NC
PubChem CID
10836

Risk for babies

Extreme risk

Infants are more vulnerable to Methamphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Methamphetamine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Methamphetamine. The classifications differ — that's the data.

AgencyYearClassificationNotes
DEA—Schedule IIwith limited approved medical use (Desoxyn® for ADHD and obesity)
CDC—primary driver of stimulant-related overdose deaths

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter methamphetamine

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Methamphetamine:

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is methamphetamine safe for kids?

Infants are more vulnerable to Methamphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain methamphetamine?

Methamphetamine appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to methamphetamine?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Methamphetamine in the baby app

Look up products containing methamphetamine, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US DEA: Methamphetamine — Schedule II Classification, Desoxyn Approved Medical Use, Clandestine Lab Precursor Control (Pseudoephedrine), and Federal Trafficking Penalties (21 USC 812; 2022) (2022) — regulatory
  2. NIDA Research Report: Methamphetamine — Dopaminergic Neurotoxicity, IDEAL Cohort Prenatal Exposure Outcomes, Meth-Associated Cardiomyopathy, Overdose Trends (Stimulant Deaths 2015–2023), and Environmental Contamination in Clandestine Labs (2023) (2023) — academic

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →